COVID-19 graphic

Inhaled sedatives could reduce lung inflammation, shorten the duration of ventilation and potentially improve survival.

London Health Sciences Centre - 

A team from Lawson Health Research Institute are being funded by the Government of Ontario’s COVID-19 Rapid Research Fund to study whether inhaled sedatives can replace those that are delivered intravenously in COVID-19 patients requiring ventilation. The multi-centre clinical trial aims to address a global shortage of intravenous (IV) sedatives while improving patient outcomes. 

CONCOR-1 Trial using blood plasma transfusions as possible treatment for COVID-19

London Health Sciences Centre - 

Researchers at Lawson Health Research Institute are taking part in a large, multi-centre study examining the use of convalescent plasma transfusions from people who have recovered from COVID-19 as a possible treatment for infected patients.

Spine scans

Findings suggest that surgical treatment results in better patient outcomes by improving function, quality of life and ability to return to work

LHSC: Victoria Hospital - 

In a randomized controlled trial from Lawson Health Research Institute, surgery was found to be superior to non-operative therapy in the treatment of chronic sciatica.

Chronic sciatica can be caused by a disc herniation which compresses a nerve in the lumbar spine causing pain from the lower back to the leg. The primary treatment options for sciatica are surgery or non-operative care. 

Pages